Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve the unaudited Financial ....
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories has informed BSE that its Board of Directors will meet on November 7, 2025 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. The trading window for dealing in the company's equity shares remains closed from October 1, 2025 until 48 hours after the results are announced to the exchanges. No financial figures or details have been shared at this stage — this is a routine pre-results intimation required under SEBI listing rules.
Investors should await the Q2 FY26 results on November 7 for actual revenue, profit and margin numbers; the stock may see volatility around the announcement date given the closed trading window for insiders.